Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 4/20 | 0.47 |
| ▸ | FAAH | O00519 | 2/20 | 0.42 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | CASP2 | P42575 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CES2 | O00748 | 3/20 | 0.38 |
| ▸ | CES1 | P23141 | 3/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1785340 | 1.00 | EPHX2 (0.47) | EPHX2FAAHHAO1MAPTKMT2A | |
| SCHEMBL944994 | 1.00 | EPHX2 (0.47) | EPHX2FAAHHAO1MAPTKMT2A | |
| SCHEMBL944529 | 1.00 | EPHX2 (0.47) | EPHX2FAAHHAO1MAPTKMT2A | |
| SCHEMBL2043850 | 0.98 | EPHX2 (0.48) | EPHX2FAAHHAO1MAPTKMT2A | |
| SCHEMBL2042990 | 0.98 | EPHX2 (0.48) | EPHX2FAAHHAO1MAPTKMT2A | |
| SCHEMBL8376668 | 0.98 | EPHX2 (0.48) | EPHX2FAAHHAO1MAPTKMT2A | |
| SCHEMBL9617463 | 0.98 | EPHX2 (0.48) | EPHX2FAAHHAO1MAPTKMT2A | |
| SCHEMBL2047359 | 0.98 | EPHX2 (0.48) | EPHX2FAAHHAO1MAPTKMT2A | |
| SCHEMBL9551958 | 0.98 | EPHX2 (0.44) | EPHX2FAAHHAO1MAPTKMT2A | |
| Ammonia Solution, Strong SCHEMBL1573561 | 0.97 | EPHX2 (0.47) | EPHX2FAAHHAO1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1381651-B1 | POLYORGANOSILOXANE EMULSION COMPOSITION AND A COSMETIC MATERIAL MADE THEREFROM | DOW CORNING TORAY CO LTD (JP) | 2011-06-29 | — | — | EP | claimed |
| US-7300648-B2 | Polyorganosiloxane emulsion composition and a cosmetic material made therefrom | DOWECORNING TORAY SILICONE, CO., LTD. (JP) | 2007-11-27 | — | — | US | claimed |
| US-20040138373-A1 | Polyorganosiloxane emulsion composition and a cosmetic material made therefrom | DOW TORAY CO., LTD. (JP) | 2004-07-15 | — | — | US | claimed |
| EP-1381651-A1 | POLYORGANOSILOXANE EMULSION COMPOSITION AND A COSMETIC MATERIAL MADE THEREFROM | Dow Corning Toray Silicone Co.,Ltd. Patent Department (JP) | 2004-01-21 | — | — | EP | claimed |
| WO-2002088253-A1 | POLYORGANOSILOXANE EMULSION COMPOSITION AND A COSMETIC MATERIAL MADE THEREFROM | DOW CORNING TORAY SILICONE CO., LTD. (JP) | 2002-11-07 | — | — | WO | claimed |
| WO-2022071465-A1 | VISCOUS COMPOSITION | 住友精化株式会社 | 2022-04-07 | — | — | WO | disclosed |
| WO-2021106901-A1 | ORAL LIQUID COMPOSITION | ライオン株式会社 | 2021-06-03 | — | — | WO | disclosed |
| WO-2020016926-A1 | NONAQUEOUS COMPOSITION FOR ORAL CAVITY | 日本ゼトック株式会社 | 2020-01-23 | — | — | WO | disclosed |
| EP-2260830-B1 | FOAMABLE SKIN WASHING AGENT | SHISEIDO CO LTD (JP) | 2018-02-21 | — | — | EP | disclosed |
| US-8946137-B2 | Foamable skin washing agent | SHISEIDO COMPANY, LTD. (JP) | 2015-02-03 | — | — | US | disclosed |
| US-20130178406-A1 | Foamable Skin Washing Agent | SHISEIDO COMPANY, LTD. (JP) | 2013-07-11 | — | — | US | disclosed |
| EP-1381651-B1 | POLYORGANOSILOXANE EMULSION COMPOSITION AND A COSMETIC MATERIAL MADE THEREFROM | DOW CORNING TORAY CO LTD (JP) | 2011-06-29 | — | — | EP | disclosed |
| US-5618637-A | MAGNETIC LAYER COMPRISING MAGNETIC POWDER DISPERSED WITHIN BINDER RESIN HAVING AMINO- OR AMMONIUM SALT GROUPS; PACKING DENSITY, ORIENTATION | TDK CORPORATION (JP) | 1997-04-08 | — | — | US | disclosed |
| EP-0726314-A1 | FIMBRILLIN PROTEIN OF $i(PORPHYROMONAS GINGIVALIS) | LION CORPORATION (JP) | 1996-08-14 | — | — | EP | disclosed |
| US-5190747-A | Fatty ester of glucose | LION CORPORATION (JP) | 1993-03-02 | — | — | US | disclosed |
| US-5109127-A | Fatty acid ester of hexose or an alkyl glucoside; tastless, good foaming power | LION CORPORATION (JP) | 1992-04-28 | — | — | US | disclosed |
| EP-0280492-B1 | LIPOSOME COMPOSITION AND ITS PRODUCTION | Takeda Chemical Industries, Ltd. (JP) | 1992-01-22 | — | — | EP | disclosed |
| US-5019394-A | Saturated Phopholipid Membrane, Drug Delivery | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1991-05-28 | — | — | US | disclosed |
| EP-0427210-A2 | Nonionic surface active agent | LION CORPORATION (JP) | 1991-05-15 | — | — | EP | disclosed |
| EP-0280492-A2 | Liposome composition and its production | Takeda Chemical Industries, Ltd. (JP) | 1988-08-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130178406-A1 | Foamable Skin Washing Agent | DIMT1, TPMT, MTAP | EPHX2 1465/4885FAAH 81/4885HAO1 449/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.